Literature DB >> 19956959

Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?

Sun-Ah Choi, Virgilio Gerald Hilario Evidente, John N Caviness, Holly A Shill, Marwan N Sabbagh, Donald J Connor, Joseph G Hentz, Charles H Adler, Thomas G Beach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19956959      PMCID： PMC2928051          DOI： 10.1007/s00401-009-0620-2

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  7 in total

Review 1.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

Review 2.  Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases.

Authors:  Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2005-01-11       Impact factor: 17.088

Review 3.  The enigma of vascular cognitive disorder and vascular dementia.

Authors:  Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2007-02-07       Impact factor: 17.088

4.  Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  Acta Neuropathol       Date:  2008-02-14       Impact factor: 17.088

5.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

6.  Defining mild cognitive impairment in Parkinson's disease.

Authors:  John N Caviness; Erika Driver-Dunckley; Donald J Connor; Marwan N Sabbagh; Joseph G Hentz; Brie Noble; Virgilio Gerald H Evidente; Holly A Shill; Charles H Adler
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

7.  The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007.

Authors:  Thomas G Beach; Lucia I Sue; Douglas G Walker; Alex E Roher; LihFen Lue; Linda Vedders; Donald J Connor; Marwan N Sabbagh; Joseph Rogers
Journal:  Cell Tissue Bank       Date:  2008-03-18       Impact factor: 1.522
  7 in total
  23 in total

1.  An update on brain imaging in parkinsonian dementia.

Authors:  Myria Petrou; Vikas Kotagal; Nicolaas I Bohnen
Journal:  Imaging Med       Date:  2012-04

2.  Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's disease.

Authors:  J D Jones; I Malaty; C C Price; M S Okun; D Bowers
Journal:  Parkinsonism Relat Disord       Date:  2012-07-07       Impact factor: 4.891

3.  Assessing medication role on neuropathological findings in Parkinson's disease.

Authors:  Charles H Adler; Joseph G Hentz; Thomas G Beach
Journal:  Mov Disord       Date:  2016-02-16       Impact factor: 10.338

Review 4.  An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group.

Authors:  Ivan Rektor; Nicolaas I Bohnen; Amos D Korczyn; Viktoria Gryb; Hrishikesh Kumar; Milica G Kramberger; Frank-Erik de Leeuw; Zvezdan Pirtošek; Irena Rektorová; Ilana Schlesinger; Jaroslaw Slawek; Peter Valkovič; Branislav Veselý
Journal:  Parkinsonism Relat Disord       Date:  2017-12-29       Impact factor: 4.891

Review 5.  The neurobiological basis of cognitive impairment in Parkinson's disease.

Authors:  Glenda M Halliday; James B Leverenz; Jay S Schneider; Charles H Adler
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

Review 6.  White matter lesions in Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Nat Rev Neurol       Date:  2011-02-22       Impact factor: 42.937

7.  Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairment.

Authors:  Charles H Adler; John N Caviness; Marwan N Sabbagh; Holly A Shill; Donald J Connor; Lucia Sue; Virgilio G H Evidente; Erika Driver-Dunckley; Thomas G Beach
Journal:  Acta Neuropathol       Date:  2010-09-14       Impact factor: 17.088

8.  Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging.

Authors:  Brittany N Dugger; Geidy E Serrano; Lucia I Sue; Douglas G Walker; Charles H Adler; Holly A Shill; Marwan N Sabbagh; John N Caviness; Jose Hidalgo; Megan Saxon-Labelle; Glenn Chiarolanza; Monica Mariner; Jonette Henry-Watson; Thomas G Beach
Journal:  J Parkinsons Dis       Date:  2012-01-01       Impact factor: 5.568

Review 9.  Neuropathological basis of nonmotor manifestations of Parkinson's disease.

Authors:  Charles H Adler; Thomas G Beach
Journal:  Mov Disord       Date:  2016-03-31       Impact factor: 10.338

10.  Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage.

Authors:  Federica Agosta; Elisa Canu; Elka Stefanova; Lidia Sarro; Aleksandra Tomić; Vladana Špica; Giancarlo Comi; Vladimir S Kostić; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2013-07-11       Impact factor: 5.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.